Zilli, T. Et Al. 2018. Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial. 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) , (Barcelona, Spain).

Zilli, T., Jorcano, S., Bral, S., Rubio, C., Bruynzeel, A., Oliveira, A., ... Abacioglu, U.(2018). Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial . 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Barcelona, Spain

Zilli, T. Et Al. "Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial," 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Barcelona, Spain, 2018

Zilli, T. Et Al. "Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial." 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) , Barcelona, Spain, 2018

Zilli, T. Et Al. (2018) . "Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial." 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) , Barcelona, Spain.

@conferencepaper{conferencepaper, author={T. Zilli Et Al. }, title={Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial}, congress name={37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)}, city={Barcelona}, country={Spain}, year={2018}}